We work closely with various partners on drug discovery projects to help find new cures for rare genetic diseases. Modelis’ research is high throughput. We leverage new technologies (CRISPR) to discover new treatments and bridge the gap from bench to bedside.
We partner with Pharmaceutical Companies, Venture Philanthropists, Genetic Sequencing Groups, and more.